ARTMS
Vancouver
About ARTMS
ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes. Artms provides the QUANTM Irradiation SystemTM (QISTM), which enables decentralized, and local production of important medical isotopes including gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $22.3M
- Funding stage: M&A
- Last round: Grant (Mar 2021)
- Website: artms.ca
Industries & Categories
Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/artms-5077 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.